Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Overall“
Suchtreffer
Begriffe & Kennungen
Ablymico · 4.5 · Liraglutide did not change the overall exposure of atorvastatin following single dose administration of atorva
Eintrag öffnenAblymico · 4.5 · Liraglutide did not change the overall exposure of griseofulvin following administration of a single dose of g
Eintrag öffnenAblymico · 4.5 · Liraglutide did not change the overall exposure of paracetamol following a single dose of 1 000 mg. Paracetamo
Eintrag öffnenAblymico · 4.8 · Overall, the frequency, type and severity of adverse reactions in the children with obesity were comparable to
Eintrag öffnenAclasta · 4.8 · Acute phase reactions The overall percentage of patients who reported acute phase reactions or post-dose sympt
Eintrag öffnenAclasta · 4.8 · Atrial fibrillation In the HORIZON – Pivotal Fracture Trial [PFT] (see section 5.1), the overall incidence of
Eintrag öffnenAclasta · 4.8 · The overall percentage of patients who experienced adverse reactions were 44.7%, 16.7% and 10.2% after the fir
Eintrag öffnenAdempas · 4.8 · Overall, the safety data is consistent with the safety profile observed in adults.
Eintrag öffnenAdempas · 4.8 · Overall, the safety data is consistent with the safety profile observed in adults.
Eintrag öffnenAkeega · 4.8 · Hepatotoxicity The overall incidence of hepatotoxicity was similar for the niraparib plus AAP (13.6%) and plac
Eintrag öffnenAkeega · 4.8 · Summary of the safety profile The overall safety profile of Akeega is based on pooled data from two clinical P
Eintrag öffnenApixaban Accord · 4.8 · 13 In the VTEt studies, the overall incidence of adverse reactions related to bleeding with apixaban was 15.6%
Eintrag öffnenApixaban Accord · 4.8 · In the NVAF studies, the overall incidence of adverse reactions related to bleeding with apixaban was 24.3% in
Eintrag öffnenApixaban Accord · 4.8 · In the NVAF studies, the overall incidence of adverse reactions related to bleeding with apixaban was 24.3% in
Eintrag öffnenApixaban Accord · 4.8 · In the VTEt studies, the overall incidence of adverse reactions related to bleeding with apixaban was 15.6% in
Eintrag öffnenApixaban Accord · 4.8 · Overall, the safety profile of apixaban in paediatric patients 28 days to < 18 years of age was similar to tha
Eintrag öffnenApixaban Accord · 4.8 · Overall, the safety profile of apixaban in paediatric patients 28 days to < 18 years of age was similar to tha
Eintrag öffnenAprovel · 4.8 · In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not di
Eintrag öffnenAprovel · 4.8 · In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not di
Eintrag öffnenAprovel · 4.8 · In placebo-controlled trials in patients with hypertension, the overall incidence of adverse events did not di
Eintrag öffnen